Please login to the form below

Not currently logged in
Email:
Password:

KaloBios names Herb Cross as CFO

He joins from Affymax

Herb Cross is to join KaloBios as the company's new chief financial officer.

After a transition period, he will succeed Jeffrey Cooper sometime in October or November, when Cooper is set to retire to spend more time with his family.

Cross joins from biopharma company Affymax, where he was also chief financial officer.

David Pritchard, president and CEO of KaloBios, described Cross as a “well respected finance professional with over sixteen years of experience”.

"His prior work in monoclonal antibody companies and his broad leadership roles in public companies will be invaluable to KaloBios as we focus on our next stage of growth and development,” added Pritchard.

This growth is being led by three drug development programmes for therapies to treat respiratory disorders and cancer.

This includes KB001-A, which is being developed in partnership with Sanofi for the treatment of Pseudomonas aeruginosa (Pa) infections as well as by KalaBios alone as cystic fibrosis treatment.

Cross said: "KaloBios has an interesting and diverse pipeline of monoclonal antibody therapeutic candidates in clinical development, in important areas of unmet medical need.” 

23rd September 2013

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics